Sterigenics
SHCPrivate Company
Funding information not available
Overview
Sterigenics, a business unit of Sotera Health, is a mission-critical provider of outsourced terminal sterilization services, safeguarding global health by ensuring product safety for over 2,800 customers. Its competitive advantage lies in a multi-modal technology platform (EO, Gamma, E-Beam, X-ray, NO2) and a vast, integrated global network offering supply chain resilience. The company's strategy focuses on capacity expansion, technological innovation, and deep regulatory expertise to capitalize on the growing, non-discretionary demand for sterilization driven by stringent global regulations and an expanding medical device market.
Technology Platform
A comprehensive, multi-modal platform offering Ethylene Oxide (EO), Gamma, Electron Beam (E-Beam), X-ray, and Nitrogen Dioxide (NO2) sterilization technologies, allowing for technology-agnostic, optimized solutions for diverse product needs.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Operates in an oligopolistic market with major competitors like STERIS. Sterigenics's advantages include the industry's largest global network, full technology agnosticism across five modalities, and vertical integration into Cobalt-60 supply through sister company Nordion.